BioReference Laboratories Inc. (BRLI) Income Statement

Income Statement for BioReference Laboratories Inc.  (BRLI) 
$ 18.93   -0.48 (-2.47%) Volume: 374.69 k 4:00 PM EST Feb 10, 2012
After Hours:  $ 18.93 0.00 (0.00%) Volume: 600  4:37 PM EST Feb 10, 2012
Statement: View:
Income [+] in Thousands of Dollars
10/2011 10/2010 10/2009 10/2008 10/2007
Operating Revenue 558,642 458,024 362,654 301,071 250,431
Total Revenue 558,642 458,024 362,654 301,071 250,431
Adjustments to Revenue - - - - -
Cost of Revenue (276,817) (223,599) (176,280) (147,869) (119,540)
Cost of Sales With Depreciation 287,853 232,252 183,524 153,831 124,029
Gross Margin 281,825 234,425 186,374 153,202 130,891
Gross Operating Profit 281,825 234,425 186,374 153,202 130,891
Selling/General/Admin Expense (207,046) (174,226) (138,281) (116,259) (98,908)
Research & Development - - - - -
Advertising - - - - -
EBITDA (Operating Income Before Depreciation) 74,779 60,199 48,093 36,943 31,983
Depreciation & Amortization (15,005) (11,821) (9,771) (8,386) (6,926)
Depreciation, Unreconciled 3,969 3,168 2,527 2,424 2,437
Amortization - - - - -
Amortization of Intangibles - - - - -
Operating Income 59,774 48,378 38,322 28,557 25,057
Operating Profit After Depreciation 59,774 48,378 38,322 28,557 25,057
Interest Income 163 151 179 269 260
Earnings from Equity Interest - - - - -
Other Income, Net 6,656 - 1,600 - -
Income, Acquired in Process R&D - - - - -
Income, Restructuring and M&A - - - - -
Other Special Charges - - - - -
Total Income Before Interest Expense (EBIT) 66,593 48,529 40,101 28,826 25,317
Interest Expense (1,747) (1,566) (1,512) (2,135) (2,410)
Income Before Tax 64,846 46,963 38,589 26,691 22,907
Income Taxes (28,487) (20,582) (16,739) (11,074) (8,950)
Minority Interest - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Other Special Charges 64,846 46,963 38,589 26,691 22,907
Net Income from Continuing Operations 36,359 26,381 21,850 15,617 13,957
Net Income from Discontinued Operations - - - - -
Net Income from Total Operations 36,359 26,381 21,850 15,617 13,957
Normalized Income 36,359 26,381 21,850 15,617 13,957
Extraordinary Income/Loss - - - - -
Special Income/Charges - - - - -
Income from Cum. Effect of Acct Change - - - - -
Income from Tax Loss Carryforward - - - - -
Net Income Available for Common 36,359 26,381 21,850 15,617 13,957
Other Gains - - - - -
Total Net Income 36,359 26,381 21,850 15,617 13,957
Net Income Available for Common 36,359 26,381 21,850 15,617 13,957
Results [+] in Dollars (Preferred Dividends in Thousands)
10/2011 10/2010 10/2009 10/2008 10/2007
Dividends Paid Per Share 0.00 0.00 0.00 0.00 0.00
Preferred Dividends - - - - -
Basic EPS from Continuing Operations 1.30 0.95 0.79 0.57 0.51
Basic EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Basic EPS from Extraordinary Income Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Basic EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Basic EPS from Total Net Income 1.30 0.95 0.79 0.57 0.51
Basic Normalized Net Income per Share 1.30 0.95 0.79 0.57 0.51
Basic EPS from Total Operations 1.30 0.95 0.79 0.57 0.51
Diluted EPS from Continuing Operations 1.29 0.94 0.78 0.56 0.51
Diluted EPS from Discontinued Operations 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Extraordinary Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Cumulative Effect of Accounting Change 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Tax Loss Carryforward 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Other Gains/Losses 0.00 0.00 0.00 0.00 0.00
Diluted EPS from Total Net Income 1.29 0.94 0.78 0.56 0.51
Diluted Normalized Net Income per Share 1.29 0.94 0.78 0.56 0.51
Excise Tax - - - - -
Diluted EPS from Total Operations 1.29 0.94 0.78 0.56 0.51
 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.